ATLASElevance Health (ELV) Q3 2026 earnings results
Elevance Health (ELV) reported EPS of $6.99 against an analyst estimate of $4.66: a beat of $2.33 (50.0%). The quarter ended Sep 30, 2026; the company reported on Wednesday, October 21, 2026, before the open.
Status: Confirmed · cross-checked Nov 2 · Source: EODHD (calendar and fundamentals, cross-checked)
Notify me when Elevance Health reports
Track ELV free Add Elevance Health to a free ATLAS watchlist.
ELV Q3 2026 results at a glance
| EPS reported | $6.99 |
|---|---|
| EPS estimate | $4.66 |
| Surprise | Beat · +$2.33 (+50.0%) |
| Quarter ended | Sep 30, 2026 |
| Reported | Oct 21, 2026, before the open |
| Status | Confirmed · cross-checked Nov 2 |
EPS is as supplied by EODHD, in US dollars per share; whether it is adjusted or GAAP follows that source. This is Elevance Health’s Q3 2026, a calendar-year company.
Elevance Health EPS surprise history: last 5 quarters
Elevance Health beat the EPS estimate in 5 of its last 5 reports, with an average surprise of +25.2%.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 21, 2026 | $4.66 | $6.99 | +50.0% | Beat | +1.2% |
| Jul 15, 2026 | $6.21 | $7.45 | +20.0% | Beat | -12.6% |
| Apr 22, 2026 | $10.81 | $12.58 | +16.4% | Beat | +5.5% |
| Jan 28, 2026 | $3.09 | $3.33 | +7.8% | Beat | +7.5% |
| Nov 18, 2025 | $0.25 | $0.33 | +32.0% | Beat | -4.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it. It is filled in a few trading days after each report.
ELV stock reaction to the report
ELV moved -1.37% in the first session that reflects the report (close of Oct 20, 2026 $440.18 to close of Oct 21, 2026 $434.13). Since the report: -6.04% (latest close $413.60 on Nov 2, 2026, against $440.18 before the reaction).
Next ELV earnings report
Elevance Health has not announced its next earnings date yet. This page shows a date only once it is confirmed. See the ELV earnings calendar.
ATLAS fair value and signal for ELV
| Last price | $412.44 (-1.8%) |
|---|---|
| ATLAS fair value | $557.37 (range $501.63–$613.11) · price is 26% below it |
| Chance of a higher close in 1 month | 52% (normal range $395.12–$433.01) |
These are model outputs from the same valuation and calibrated model as the Elevance Health stock page. They describe an ordinary period and are not a forecast of any particular outcome.
Elevance Health Q3 2026 earnings: frequently asked questions
Did Elevance Health beat earnings estimates for Q3 2026?
Elevance Health reported EPS of $6.99 against an analyst estimate of $4.66: a beat of $2.33 (50.0%).
When did Elevance Health report Q3 2026 results?
Elevance Health reported on Wednesday, October 21, 2026, before the open, for the quarter ended Wednesday, September 30, 2026.
How often does ELV beat EPS estimates?
In its last 5 reports with a recorded result, Elevance Health beat the EPS estimate 5 times; the average surprise was +25.2%. Past results do not predict the next one.
How does ATLAS confirm a result?
A result is published only after it is cross-checked: the EODHD earnings calendar and the EODHD fundamentals feed must show the same EPS for the same fiscal period, or the same value must appear in two consecutive checks. Unconfirmed figures are never published. If the figures are revised later, this page updates.
Educational information, not investment advice. Disclaimer